Covestor LTD Biotechnology

Covestor LTD

$150 Million
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LXRX Lexicon Pharmaceuticals, Inc.	$166M	$0 0.0% of portfolio	81	Q4 2024 Added 22.73%
LQDA Liquidia Corp	$801M	$0 0.0% of portfolio	8	Q4 2024 Reduced 89.04%
MGNX Macrogenics Inc	$86M	$0 0.0% of portfolio	18	Q1 2025 Added 5.88%
MNKD Mannkind Corp	$983M	$0 0.0% of portfolio	24	Q4 2024 Added 9.09%
MDXG Mimedx Group, Inc.	$736M	$0 0.0% of portfolio	42	Q1 2025 Reduced 82.2%
NAUT Nautilus Biotechnology, Inc.	$99.7M	$0 0.0% of portfolio	8	Q4 2024 Added 14.29%
NKTR Nektar Therapeutics	$4.4B	$0 0.0% of portfolio	5	Q2 2024 Reduced 80.0%
NRIX Nurix Therapeutics, Inc.	$583M	$0 0.0% of portfolio	5	Q3 2024 Reduced 28.57%
NUVB Nuvation Bio Inc.	$452M	$0 0.0% of portfolio	37	Q1 2025 Added 2.78%
OCUL Ocular Therapeutix, Inc	$770M	$0 0.0% of portfolio	15	Q4 2024 Added 7.14%
OLMA Olema Pharmaceuticals, Inc.	$185M	$0 0.0% of portfolio	17	Q1 2025 Added 142.86%
PMCB Pharma Cyte Biotech, Inc.	$23.4M	$0 0.0% of portfolio	275	Q4 2024 Added 21.68%
PHAT Phathom Pharmaceuticals, Inc.	$344M	$0 0.0% of portfolio	7	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$58.9M	$0 0.0% of portfolio	6	Q4 2024 Added 20.0%
PRTA Prothena Corp Public LTD CO	$302M	$0 0.0% of portfolio	4	Q1 2024 Added 33.33%
PTCT Ptc Therapeutics, Inc.	$3.54B	$0 0.0% of portfolio	4	Q4 2024 Reduced 20.0%
RAPT Rapt Therapeutics, Inc.	$242M	$0 0.0% of portfolio	73	Q1 2025 Added 231.82%
RXRX Recursion Pharmaceuticals, Inc.	$953M	$0 0.0% of portfolio	21	Q4 2024 Added 75.0%
RGNX Regenxbio Inc.	$396M	$0 0.0% of portfolio	7	Q3 2024 Added 75.0%
RLAY Relay Therapeutics, Inc.	$428M	$0 0.0% of portfolio	26	Q1 2025 Added 136.36%
REPL Replimune Group, Inc.	$512M	$0 0.0% of portfolio	11	Q1 2024 Added 83.33%
RYTM Rhythm Pharmaceuticals, Inc.	$3.66B	$0 0.0% of portfolio	6	Q1 2025 Reduced 40.0%
SANA Sana Biotechnology, Inc.	$803M	$0 0.0% of portfolio	28	Q1 2025 Added 3.7%
SRRK Scholar Rock Holding Corp	$1.74B	$0 0.0% of portfolio	4	Q4 2024 Reduced 42.86%
SNDX Syndax Pharmaceuticals Inc	$523M	$0 0.0% of portfolio	9	Q1 2025 Added 80.0%
TNGX Tango Therapeutics, Inc.	$478M	$0 0.0% of portfolio	34	Q1 2025 Added 240.0%
TGTX Tg Therapeutics, Inc.	$5.23B	$0 0.0% of portfolio	8	Q3 2024 Reduced 27.27%
TVTX Travere Therapeutics, Inc.	$1.09B	$0 0.0% of portfolio	7	Q4 2024 Reduced 36.36%
TYRA Tyra Biosciences, Inc.	$408M	$0 0.0% of portfolio	6	Q2 2024 New
VTYX Ventyx Biosciences, Inc.	$115M	$0 0.0% of portfolio	30	Q4 2024 Added 7.14%
VERA Vera Therapeutics, Inc.	$619M	$0 0.0% of portfolio	4	Q1 2025 Added 33.33%
VRCA Verrica Pharmaceuticals Inc.	$327M	$0 0.0% of portfolio	545	Q1 2025 New
VERV Verve Therapeutics, Inc.	$669M	$0 0.0% of portfolio	14	Q4 2024 Added 7.69%
VIR Vir Biotechnology, Inc.	$730M	$0 0.0% of portfolio	12	Q1 2025 Reduced 55.56%
VRDN Viridian Therapeutics, Inc.\De	$637M	$0 0.0% of portfolio	5	Q4 2024 Reduced 28.57%
WVE Wave Life Sciences Ltd.	$601M	$0 0.0% of portfolio	14	Q4 2024 New
XNCR Xencor Inc	$528M	$0 0.0% of portfolio	6	Q1 2025 Added 20.0%
XOMA Xoma Corp	$303M	$0 0.0% of portfolio	0	Q1 2025 Sold Out
ZNTL Zentalis Pharmaceuticals, Inc.	$77.5M	$0 0.0% of portfolio	23	Q4 2024 Added 9.52%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.